Artelo Biosciences Statistics Share Statistics Artelo Biosciences has 704.42K
shares outstanding. The number of shares has increased by 0.02%
in one year.
Shares Outstanding 704.42K Shares Change (YoY) 0.02% Shares Change (QoQ) -0.23% Owned by Institutions (%) 3.26% Shares Floating 699.83K Failed to Deliver (FTD) Shares 7,018 FTD / Avg. Volume 1.05%
Short Selling Information The latest short interest is 30.59K, so 4.34% of the outstanding
shares have been sold short.
Short Interest 30.59K Short % of Shares Out 4.34% Short % of Float 4.37% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.81 and the forward
PE ratio is -1.08.
Artelo Biosciences's PEG ratio is
0.02.
PE Ratio -0.81 Forward PE -1.08 PS Ratio 0 Forward PS n/a PB Ratio 0.42 P/FCF Ratio -1.02 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Artelo Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 18.36,
with a Debt / Equity ratio of 0.
Current Ratio 18.36 Quick Ratio 18.36 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -2057.4
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.68M Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -209K Effective Tax Rate 2.07%
Stock Price Statistics The stock price has increased by 30.95% in the
last 52 weeks. The beta is 1.36, so Artelo Biosciences's
price volatility has been higher than the market average.
Beta 1.36 52-Week Price Change 30.95% 50-Day Moving Average 10.84 200-Day Moving Average 7.55 Relative Strength Index (RSI) 37.28 Average Volume (20 Days) 670,218
Income Statement
Revenue n/a Gross Profit n/a Operating Income -10.29M Net Income -10.08M EBITDA -10.29M EBIT -10.29M Earnings Per Share (EPS) -3.49
Full Income Statement Balance Sheet The company has 6.89M in cash and 63K in
debt, giving a net cash position of 6.83M.
Cash & Cash Equivalents 6.89M Total Debt 63K Net Cash 6.83M Retained Earnings -31.02M Total Assets 15.5M Working Capital 12.51M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.01M
and capital expenditures 0, giving a free cash flow of -8.01M.
Operating Cash Flow -8.01M Capital Expenditures n/a Free Cash Flow -8.01M FCF Per Share -16.97
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ARTL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ARTL is $30,
which is 203% higher than the current price. The consensus rating is "Buy".
Price Target $30 Price Target Difference 203% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 13, 2025. It was a
backward
split with a ratio of 1:6.
Last Split Date Jun 13, 2025 Split Type backward Split Ratio 1:6
Scores Altman Z-Score -0.68 Piotroski F-Score 2
